Start for free

Shilpa Medicare Limited

NSE: SHILPAMEDHealthcare

Shilpa Medicare Limited Share Price & Analysis

₹964.15+0.84%Updated 4 Sept 2026, 03:30 pm IST
LTP
₹964.15+0.84%
Open
₹955.95
High
₹971.60
Low
₹947.80
Close
₹964.15
52W High
₹975.00
52W Low
₹259.50
Volume
653K
Lot Size
1
Sector
Healthcare
Market Cap
₹19K Cr
Face Value
₹1
Mid Cap

Price Chart

Candle
Range

Fundamentals

P/E
66.30
Sector P/E
54.70
P/B
4.16
EPS
₹12.43
ROE
8.99%
ROCE
10.90%
D/E Ratio
0.25
Div Yield
0.06%
Book Value
₹132.00

Strengths

  • Low debt relative to equity (D/E 0.3x)

Concerns

  • Trading near 52-week high (₹975)

Peer Comparison

CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
SUNPHARMA
Sun Pharmaceutical Industries Limited
₹1,899
₹4.6L Cr36.15.461620.50.07
DIVISLAB
Divi's Laboratories Limited
₹9,100
₹2.4L Cr81.114.4216.5220.01
TORNTPHARM
Torrent Pharmaceuticals Limited
₹4,857
₹1.8L Cr82.819.5827.415.20.33
APOLLOHOSP
Apollo Hospitals Enterprise Limited
₹8,650
₹1.2L Cr59.113.1321.217.40.88
CIPLA
Cipla Limited
₹1,385
₹1.1L Cr31.33.2511.615.50.01
ZYDUSLIFE
Zydus Lifesciences Limited
₹1,120
₹1.1L Cr234.1621.221.10.38
LAURUSLABS
Laurus Labs Limited
₹1,840
₹99K Cr90.918.7418.317.80.46

Showing 7 peers in the same sector · Sorted by market cap

Shareholding Pattern

SHILPAMED · as of Mar 2026

Promoters44.23%
FII10.97%1.07pp
DII7.55%0.72pp
Public37.25%0.34pp
CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters50.01%50.01%44.39%44.33%44.23%44.23%
FII8.52%5.63%9.08%9.59%9.90%10.97%
DII0.06%1.65%7.61%8.18%8.27%7.55%
Public41.41%42.71%38.91%37.90%37.59%37.25%

Corporate Events

Dividend - Re 0.60 Per Share

Dividend3 Sept 2026

To consider and approve the Unaudited financial results for the period ended Jun 30, 2026

Results4 Aug 2026

Bonus 1:1

Bonus2 Oct 2025

Dividend - Re 1 Per Share

Dividend16 Sept 2025

Annual General Meeting

AGM5 Sept 2024

Annual General Meeting

AGM21 Sept 2023

Latest News

All news

Shilpa Medicare reports Q1FY26 financial results

*Shilpa Medicare reports Q1FY26 financial results* from its board meeting. The company announced consolidated financial results for the quarter ended June 30, 2026. Key figures include revenue of **₹127.4 crore** and net profit of **₹18.2 crore**, up **14% YoY**. Performance reflects sustained growth in API and formulations segments. 📊 *STOCKS:* $SHILPAMED | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Earnings

NSE Filing5 Aug
High Impact

Shilpa Medicare Bengaluru unit fails USFDA inspection

*Shilpa Medicare Bengaluru unit fails USFDA inspection* — The company's Bengaluru facility has received **5 observations** following a USFDA pre-approval inspection (PAI), signaling potential delays in product approvals. This regulatory setback could impact export plans and investor sentiment. Immediate corrective actions may be required to address compliance issues. 📊 *STOCKS:* SHILPAM | 🏢 *SECTOR:* Pharma | #HIGHIMPACT #USFDA

Medical Dialogues1 Jun
High Impact

Shilpa Biologicals signs co-development deal with Finland's Orion

*Shilpa Biologicals signs co-development deal with Finland's Orion* Shilpa Biologicals Pvt Ltd, a wholly owned subsidiary of Shilpa Medicare, has entered into a co-development and supply agreement with Orion Corporation of Finland. The partnership focuses on advancing and supplying pharmaceutical products. This strategic move enhances Shilpa's global footprint and R&D capabilities. 📊 *STOCKS:* SHILPAMED | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #pharma

NSE Filing30 Jun
Medium Impact

Shilpa Medicare commissions ADC manufacturing facility via subsidiary

*Shilpa Medicare commissions ADC manufacturing facility via subsidiary*. A state-of-the-art GMP facility for Antibody Drug Conjugates has been commissioned by Shilpa Biologicals, a material subsidiary. This marks a strategic expansion into high-value biopharma products. The move strengthens its footprint in the global specialty pharmaceuticals market. 📊 *STOCKS:* SHILPAMED | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #ADC

NSE Filing24 Jun
Medium Impact

Shilpa Medicare shares to watch after investor presentation

*Shilpa Medicare shares to watch after investor presentation.* The company shared an investor presentation through a BSE filing, highlighting business updates and strategy. No major financial figures or announcements were disclosed. Traders may assess visuals and commentary for sentiment cues. 📊 *STOCKS:* $SHILPAMED | 🏢 *SECTOR:* Pharma | #LOWIMPACT #InvestorPresentation

NSE Filing5 Aug
Low Impact

Shilpa Medicare sets dividend record date

*Shilpa Medicare sets dividend record date* for **04-Sep-2026**, marking the cutoff for shareholder eligibility. The company has informed the NSE about the record date for dividend distribution. No dividend amount or payment date has been disclosed yet. Investors must hold shares by the record date to qualify. 📊 *STOCKS:* $SHILPAMED | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Dividend

NSE Filing5 Aug
Low Impact

Financials

Quarterly Results

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
₹437 Cr
6.6%
₹410 Cr
10.8%
₹370 Cr
15.3%
₹321 Cr
3.0%
₹331 Cr
3.8%
₹319 Cr
7.3%
₹344 Cr
17.4%
₹293 Cr
Op. Profit
₹120 Cr
5.3%
₹114 Cr
5.6%
₹108 Cr
18.7%
₹91 Cr
15.2%
₹79 Cr
2.5%
₹81 Cr
5.8%
₹86 Cr
22.9%
₹70 Cr
OPM
27.0%
3.6%
28.0%
3.4%
29.0%
3.6%
28.0%
16.7%
24.0%
4.0%
25.0%
0.0%
25.0%
4.2%
24.0%
Net Profit
₹108 Cr
140.0%
₹45 Cr
2.3%
₹44 Cr
6.4%
₹47 Cr
213.3%
₹15 Cr
53.1%
₹32 Cr
77.8%
₹18 Cr
28.6%
₹14 Cr
EPS (₹)
5.51
141.7%
2.28
1.3%
2.25
6.2%
2.4
224.3%
0.74
54.3%
1.62
76.1%
0.92
27.8%
0.72

Values in ₹ Cr · Source: Screener.in

Annual Profit & Loss

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Revenue
₹1.5K Cr
19.8%
₹1.3K Cr
11.8%
₹1.1K Cr
9.6%
₹1.0K Cr
8.3%
₹1.1K Cr
26.9%
₹899 Cr
1.0%
₹908 Cr
23.9%
₹733 Cr
7.1%
₹789 Cr
1.3%
₹779 Cr
Expenses
₹1.1K Cr
14.3%
₹962 Cr
6.1%
₹907 Cr
4.2%
₹947 Cr
0.7%
₹940 Cr
30.9%
₹718 Cr
4.4%
₹688 Cr
17.6%
₹585 Cr
7.7%
₹634 Cr
3.3%
₹614 Cr
Op. Profit
₹435 Cr
36.4%
₹319 Cr
33.5%
₹239 Cr
141.4%
₹99 Cr
51.0%
₹202 Cr
11.6%
₹181 Cr
17.4%
₹219 Cr
48.0%
₹148 Cr
4.5%
₹155 Cr
6.1%
₹165 Cr
OPM
28.0%
12.0%
25.0%
19.0%
21.0%
133.3%
9.0%
50.0%
18.0%
10.0%
20.0%
16.7%
24.0%
20.0%
20.0%
0.0%
20.0%
4.8%
21.0%
Other Income
₹39 Cr
587.5%
₹-8 Cr
153.3%
₹15 Cr
11.8%
₹17 Cr
19.0%
₹21 Cr
76.7%
₹90 Cr
429.4%
₹17 Cr
48.5%
₹33 Cr
50.0%
₹22 Cr
46.7%
₹15 Cr
Interest
₹59 Cr
22.4%
₹76 Cr
17.4%
₹92 Cr
55.9%
₹59 Cr
43.9%
₹41 Cr
86.4%
₹22 Cr
340.0%
₹5 Cr
25.0%
₹4 Cr
33.3%
₹3 Cr
0.0%
₹3 Cr
Depreciation
₹120 Cr
6.2%
₹113 Cr
4.6%
₹108 Cr
12.5%
₹96 Cr
20.0%
₹80 Cr
48.1%
₹54 Cr
22.7%
₹44 Cr
4.8%
₹42 Cr
13.5%
₹37 Cr
19.4%
₹31 Cr
PBT
₹295 Cr
141.8%
₹122 Cr
125.9%
₹54 Cr
242.1%
₹-38 Cr
137.3%
₹102 Cr
47.7%
₹195 Cr
3.7%
₹188 Cr
38.2%
₹136 Cr
0.7%
₹137 Cr
6.2%
₹146 Cr
Tax %
18.0%
50.0%
36.0%
12.2%
41.0%
315.8%
-19.0%
146.3%
41.0%
64.0%
25.0%
38.9%
18.0%
5.3%
19.0%
24.0%
25.0%
13.8%
29.0%
Net Profit
₹243 Cr
211.5%
₹78 Cr
143.8%
₹32 Cr
203.2%
₹-31 Cr
150.8%
₹61 Cr
58.2%
₹146 Cr
5.8%
₹155 Cr
40.9%
₹110 Cr
6.8%
₹103 Cr
1.0%
₹104 Cr
EPS (₹)
12.44
211.0%
4
117.4%
1.84
198.4%
-1.87
153.6%
3.49
61.5%
9.06
5.3%
9.57
39.1%
6.88
6.7%
6.45
3.9%
6.71
Div Payout
5.0%
58.3%
12.0%
0.0%
0.0%
100.0%
16.0%
166.7%
6.0%
0.0%
6.0%
14.3%
7.0%
40.0%
5.0%
25.0%
4.0%

Values in ₹ Cr · Source: Screener.in

Balance Sheet

ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Liabilities
Equity Capital
₹20 Cr
100.0%
₹10 Cr
11.1%
₹9 Cr
0.0%
₹9 Cr
0.0%
₹9 Cr
12.5%
₹8 Cr
0.0%
₹8 Cr
0.0%
₹8 Cr
0.0%
₹8 Cr
0.0%
₹8 Cr
Reserves
₹2.6K Cr
9.3%
₹2.4K Cr
30.7%
₹1.8K Cr
1.4%
₹1.8K Cr
2.1%
₹1.8K Cr
23.3%
₹1.5K Cr
11.4%
₹1.3K Cr
11.1%
₹1.2K Cr
10.4%
₹1.1K Cr
10.0%
₹979 Cr
Borrowings
₹660 Cr
12.2%
₹588 Cr
37.2%
₹937 Cr
17.4%
₹798 Cr
16.8%
₹683 Cr
19.3%
₹846 Cr
116.9%
₹390 Cr
101.0%
₹194 Cr
1.6%
₹191 Cr
20.7%
₹241 Cr
Other Liabilities
₹455 Cr
26.4%
₹360 Cr
3.7%
₹347 Cr
7.4%
₹323 Cr
12.7%
₹370 Cr
20.1%
₹308 Cr
14.1%
₹270 Cr
23.9%
₹218 Cr
2.2%
₹223 Cr
8.6%
₹244 Cr
Total Liabilities
₹3.7K Cr
11.9%
₹3.3K Cr
7.0%
₹3.1K Cr
6.5%
₹2.9K Cr
1.0%
₹2.9K Cr
9.3%
₹2.6K Cr
32.3%
₹2.0K Cr
23.5%
₹1.6K Cr
7.4%
₹1.5K Cr
1.8%
₹1.5K Cr
Assets
Fixed Assets
₹1.6K Cr
12.3%
₹1.4K Cr
2.4%
₹1.4K Cr
1.2%
₹1.4K Cr
1.9%
₹1.3K Cr
20.8%
₹1.1K Cr
70.9%
₹650 Cr
16.5%
₹558 Cr
4.5%
₹534 Cr
8.5%
₹492 Cr
CWIP
₹884 Cr
7.5%
₹822 Cr
14.3%
₹719 Cr
9.8%
₹655 Cr
29.4%
₹506 Cr
6.5%
₹541 Cr
18.8%
₹666 Cr
55.2%
₹429 Cr
104.3%
₹210 Cr
48.9%
₹141 Cr
Investments
₹58 Cr
65.7%
₹35 Cr
12.5%
₹40 Cr
7.0%
₹43 Cr
26.5%
₹34 Cr
61.9%
₹21 Cr
110.0%
₹10 Cr
400.0%
₹2 Cr
98.6%
₹140 Cr
44.7%
₹253 Cr
Other Assets
₹1.2K Cr
12.8%
₹1.0K Cr
9.2%
₹950 Cr
13.4%
₹838 Cr
15.6%
₹993 Cr
3.5%
₹959 Cr
44.9%
₹662 Cr
6.6%
₹621 Cr
1.0%
₹615 Cr
4.8%
₹587 Cr
Total Assets
₹3.7K Cr
11.9%
₹3.3K Cr
7.0%
₹3.1K Cr
6.5%
₹2.9K Cr
1.0%
₹2.9K Cr
9.3%
₹2.6K Cr
32.3%
₹2.0K Cr
23.5%
₹1.6K Cr
7.4%
₹1.5K Cr
1.8%
₹1.5K Cr

Values in ₹ Cr · Source: Screener.in

Cash Flow Statement

ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Operating CF
₹342 Cr
159.1%
₹132 Cr
3.6%
₹137 Cr
23.9%
₹180 Cr
71.4%
₹105 Cr
123.4%
₹47 Cr
62.1%
₹124 Cr
15.6%
₹147 Cr
226.7%
₹45 Cr
21.6%
₹37 Cr
Investing CF
₹-339 Cr
71.2%
₹-198 Cr
15.8%
₹-171 Cr
26.3%
₹-232 Cr
18.9%
₹-286 Cr
29.2%
₹-404 Cr
39.3%
₹-290 Cr
48.0%
₹-196 Cr
1860.0%
₹-10 Cr
96.1%
₹-257 Cr
Financing CF
₹14 Cr
77.8%
₹63 Cr
34.0%
₹47 Cr
2.2%
₹46 Cr
44.6%
₹83 Cr
81.0%
₹436 Cr
147.7%
₹176 Cr
1660.0%
₹10 Cr
116.4%
₹-61 Cr
119.5%
₹313 Cr
Net Cash Flow
₹17 Cr
666.7%
₹-3 Cr
123.1%
₹13 Cr
285.7%
₹-7 Cr
92.9%
₹-98 Cr
224.1%
₹79 Cr
690.0%
₹10 Cr
125.6%
₹-39 Cr
50.0%
₹-26 Cr
128.0%
₹93 Cr
Free Cash Flow
₹-28 Cr
74.8%
₹-111 Cr
131.3%
₹-48 Cr
4.3%
₹-46 Cr
79.6%
₹-226 Cr
25.2%
₹-302 Cr
37.3%
₹-220 Cr
45.7%
₹-151 Cr
64.1%
₹-92 Cr
16.5%
₹-79 Cr

Values in ₹ Cr · Source: Screener.in

Key Ratios History

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Debtor Days
123d
2.4%
126d
0.8%
125d
10.6%
113d
8.9%
124d
40.9%
88d
11.1%
99d
2.0%
101d
1.0%
102d
27.5%
80d
Inventory Days
291d
5.8%
309d
0.0%
309d
10.4%
280d
17.2%
338d
20.8%
427d
43.3%
298d
12.0%
266d
37.1%
194d
3.7%
187d
Days Payable
113d
21.5%
93d
40.4%
156d
24.8%
125d
10.1%
139d
52.7%
91d
25.4%
122d
6.1%
115d
8.5%
106d
3.6%
110d
Cash Conv. Cycle
301d
12.0%
342d
23.0%
278d
3.7%
268d
17.0%
323d
24.0%
425d
54.5%
275d
8.7%
253d
33.9%
189d
20.4%
157d
Working Capital Days
51d
36.3%
80d
66.7%
48d
469.2%
-13d
116.9%
77d
6.9%
72d
5.9%
68d
30.6%
98d
0.0%
98d
24.1%
79d
ROCE
11.0%
37.5%
8.0%
60.0%
5.0%
400.0%
1.0%
83.3%
6.0%
25.0%
8.0%
33.3%
12.0%
33.3%
9.0%
10.0%
10.0%
28.6%
14.0%

Source: Screener.in · Lower days = better efficiency

Related Analysis

Same Sector

ALKEMAlkem Laboratories LimitedNeutralAPOLLOHOSPApollo Hospitals Enterprise LimitedNeutralAUROPHARMAAurobindo Pharma LimitedNeutralBIOCONBiocon LimitedNeutralCIPLACipla LimitedNeutral

Frequently Asked Questions

What is Shilpa Medicare Limited share price today?
Shilpa Medicare Limited (SHILPAMED) is currently trading at ₹964.15 on NSE, up 0.84% as of the last market session. Prices update daily after market close on MarketNetra.
Is Shilpa Medicare Limited available in F&O (Futures & Options)?
Yes, Shilpa Medicare Limited (SHILPAMED) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Shilpa Medicare Limited 52-week high and low?
Shilpa Medicare Limited's 52-week high is ₹975 and the 52-week low is ₹259.5. The current price of ₹964.15 is 1.1% below the 52W high.
What is Shilpa Medicare Limited P/E ratio?
Shilpa Medicare Limited's current P/E ratio is 66.3. This indicates the market is paying ₹66.3 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Shilpa Medicare Limited options?
Shilpa Medicare Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade SHILPAMED options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.